M. Pharm.

Hridya A. joined as Lecturer in the Department of Pharmacy Practice, Amrita School of Pharmacy in May 2019. She has around two years experience in teaching. She has served as Assistant Professor from 26th July 2017 to 30th April 2019 in Pharmacy Practice Department at Shree Devi College Of Pharmacy, Mangalore. She has completed B. Pharm and M. Pharm from Amrita Vishwa Vidyapeetham in 2010 and 2016 respectively.


Publication Type: Journal Article

Year of Publication Title


Naveen Kumar Panicker, Hridya A., and Rahuveer Prabhu, “Comparison of Efficacy and Safety Profile of Oral Iron Formulations in Patients with Iron Deficiency Anemia”, International Journal of Pharmaceutical Sciences Review and Research, vol. 41, no. 2, pp. 248-252, 2016.[Abstract]

The aim of the study is to compare the efficacy and safety profile of oral iron formulations in iron deficiency anemia. A prospective
study in patients with anemia receiving oral ferric ammonium citrate, ferrous fumarate, ferrous sulfate and ferrous calcium citrate
respectively were included. Demographic details, clinical history, baseline hemoglobin, anemia indices data were recorded in a case
record form. The patients were followed up once in 3 weeks for 3 months and observed for hematological improvement and
adverse drug reactions (ADRs). The data was analyzed using paired t-test, ANOVA and Pearson Chi square test. Out of 66 patients, 11
patients received ferric ammonium citrate, 23 received ferrous fumarate, 20 received ferrous sulfate and 12 received ferrous
calcium citrate. Ferric ammonium citrate, ferrous fumarate ferrous sulfate and ferrous calcium citrate have significantly (P<0.0001)
improved mean hemoglobin and anemia indices at the end of study, however, there was no significant differences between the
groups when compared. All four formulations showed similar ADR profile, there was no significant difference in adverse reactions.
Cost of therapy incurred to patients treated with ferrous fumarate was low when compared to other drugs.

More »»